Sign in

CIK 0001662774

  • Non-accelerated filer
  • Smaller reporting company

IRulya Therapeutics Inc.

Sign in to watch
Ticker
IRLA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
901024039
Phone
+1 203-208-8994
Business address
101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
Former names
Quince Therapeutics, Inc., Cortexyme, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-05-19 Lamond David Director Purchase +400 $54.09 $22K 1,659,184
2020-05-19 Lamond David Director Purchase +5,906 $55.42 $327K 1,665,090
2020-05-19 Lamond David Director Purchase +32,894 $56.42 $1.9M 1,697,984
2020-05-15 Lamond David Director Purchase +1,263 $46.30 $58K 1,654,599
2020-05-15 Lamond David Director Purchase +985 $48.37 $48K 1,655,584
2020-05-15 Lamond David Director Purchase +1,600 $48.96 $78K 1,657,184
2020-05-15 Lamond David Director Purchase +1,000 $50.71 $51K 1,658,184
2020-05-15 Lamond David Director Purchase +500 $52.20 $26K 1,658,684
2020-05-15 Lamond David Director Purchase +100 $53.10 $5K 1,658,784
2020-05-14 Holsinger Leslie Executive Vice President Grant or award · Stock Option (Right to Buy) +30,000 30,000
2020-05-14 LOWE CHRISTOPHER P. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +30,000 30,000
2020-05-14 McDowell Caryn Gordon Chief Legal & Adm. Officer Grant or award · Stock Option (Right to Buy) +200,000 200,000
2020-04-02 Detke Michael J. Chief Medical Officer Option exercise +5,515 $6.91 $38K 22,746
2020-04-02 Detke Michael J. Chief Medical Officer Option exercise · Stock Option (Right to Buy) −5,515 109,606
2020-02-10 Lamond David Director Grant or award +30,000 $50.00 $1.5M 1,653,336
2020-02-07 Detke Michael J. Chief Medical Officer Option exercise +17,231 $6.91 $119K 17,231
2020-02-07 Detke Michael J. Chief Medical Officer Option exercise · Stock Option (Right to Buy) −17,231 115,121
2020-02-06 Detke Michael J. Chief Medical Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000
2020-02-06 Gafric Kristen SVP, Legal & Administration Grant or award · Stock Option (Right to Buy) +100,000 100,000
2020-02-06 Dominy Stephen S. Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000

Page 15 of 18 · 350 trades